Scientists from The University of Texas Health Science Center at San Antonio have discovered a potential new drug that could ...

A study revealed highly specific gut microbiome signatures for NAFLD, using machine learning to differentiate the disease ...

Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...